Clinical Trial Update: Efficacy and Tolerability of AP707 in Patients With Chronic Pain Due to Diabetic Polyneuropathy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the efficacy and tolerability of AP707 in chronic pain due to diabetic polyneuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathies
• Diabetic Polyneuropathy
• Pain
• Peripheral Neuralgia

Drugs mentioned

• AP707

Snippet

Sponsor: Apurano Pharmaceuticals GmbH | Conditions: Pain, Pain Syndrome | Phase 3 | Status: UNKNOWN